Blood test could predict who gets severe radiation damage
NCT ID NCT00893035
Summary
This study tested whether a simple blood test could predict which breast and prostate cancer patients would develop severe long-term side effects from radiation therapy. Researchers measured how certain immune cells reacted to radiation in the lab. The goal was to identify the 5% of patients at highest risk so doctors could adjust treatment for everyone else.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRLC Val d'Aurelle
Montpellier, 34000, France
Conditions
Explore the condition pages connected to this study.